Molecular BiologyAnnals of the Rheumatic DiseasesPeer-reviewed
Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against autoimmune diseases
Ronghan Liu, Yuehong Chen, Wenyu Fu…·C.-J. Liu
This study identifies Fexofenadine as an inhibitor of TNF signaling through targeting cytosolic phospholipase A2, showing therapeutic potential in autoimmune diseases.
59 citations